NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/08/2023
Back to search
Official data from USPTO
ONCO X
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ONCO X
ST13
US500000090662587Class
7, 9, 10, 40, 42
Filing
90662587
Registration
7129280
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
36
Latest update
08/08/2023
Trademark type
Word
Nice classes
7, 9, 10, 40, 42
Filing date
04/21/2021
Registration date
08/08/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/08/2023
Last transaction
08/08/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
64
Owner location
GÖTEBORG, SE
Examiner
HACK, ANDREA R
Law office
L80
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
CELLINK BIOPRINTING AB
Cellink AB
Representatives
Margarita Wallach, Esq. MCCARTER & ENGLISH, LLP
Technical classification
Nice Classes
Class 7Class 9Class 10Class 40Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 7
3D printers; Three-dimensional (3D) bioprinters; 3D bioprinters; Machines for manufacturing three dimensional (3D) living tissues; Dispensing machines for use in the manufacture of living tissue
Class 9
Instruction manuals in electronic formatdownloadable instruction manuals for 3D bioprinting of tissues and organs; electronic clinicians training simulators; Imaging devices for scientific purposes for use in 3D bioprinting and 3D bioprinting of tissues and organs; Apparatus and instruments for microscopy for use in 3D bioprinting and 3D bioprinting of tissues and organs; Liquid dosage devices that measure the amounts to be dispensedfor non-medical use
Class 10
Medical devicesinfusion pumps for delivering measured amounts of solutions into the bloodstream over time
Class 40
Custom 3D printing; custom 3D bioprinting; Custom bioprinting
Class 42
Scientificmedical and bioprinting laboratory services for use in 3D bioprinting and 3D bioprinting of tissues and organs; scientificmedical and bioprinting laboratory analysis; Laboratory research in the field of chemistrymedicinebioprinting and 3D bioprinting; authentication in the field of 3D bioprinting and bioprinting; quality control in the field of bioprinting and 3D bioprinting; Technological consultancy in the field of 3D bioprinting and bioprinting; Consultancy relating to scientificmedical and bioprinting and 3D bioprinting laboratory testing; Consultancy relating to pharmaceutical research and development; Consultancy in the field of scientific research
Publications
History of USPTO decisions and trademark events.
36 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
08/08/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/23/2023
PUBO
PUBLISHED FOR OPPOSITION
05/23/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/03/2023
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
04/19/2023
ALIE
ASSIGNED TO LIE
04/15/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/09/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
04/09/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
04/09/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
04/09/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
04/09/2023
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
02/15/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/22/2022
GNRT
NON-FINAL ACTION E-MAILED
12/22/2022
CNRT
NON-FINAL ACTION WRITTEN
12/22/2022
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
12/15/2022
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
11/29/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/13/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
11/13/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
11/13/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
11/13/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
11/13/2022
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
05/02/2022
GNFR
FINAL REFUSAL E-MAILED
05/02/2022
CNFR
FINAL REFUSAL WRITTEN
05/02/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/28/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/28/2022
ALIE
ASSIGNED TO LIE
04/25/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/20/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/20/2021
GNRT
NON-FINAL ACTION E-MAILED
10/20/2021
CNRT
NON-FINAL ACTION WRITTEN
10/20/2021
DOCK
ASSIGNED TO EXAMINER
10/04/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/28/2021
NWAP
NEW APPLICATION ENTERED
04/24/2021
Continuous trademark protection
Get notified about every new filing that threatens ONCO X or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.